Author:
Van der Auwera P,Scorneaux B
Abstract
The in vitro susceptibility of human isolates of Campylobacter jejuni was investigated with 27 antibiotics and 8 combinations of beta-lactams with clavulanic acid or sulbactam. Ansamycin, the new quinolines, erythromycin, and cefpirome were the most active drugs against C. jejuni; amoxicillin, ampicillin, cefotaxime, and ceftazidime 90% of the isolates, greater than or equal to 50 mg/liter). The activity of various beta-lactams was unchanged by the addition of clavulanic acid or sulbactam.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference23 articles.
1. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination;Adam D.;Antimicrob. Agents Chemother.,1982
2. Barry A. L. 1980. Procedures for testing antibiotics in agar media: theoretical considerations p. 1-23. In V. L. Lorian (ed.) Antibiotics in laboratory medicine. The Williams & Wilkins Co. Baltimore.
3. Studies of Campylobacterjejuni in patients with inflammatory bowel disease;Blaser M. J.;Gastroenterology,1984
4. Intestinal antisepsis;Bornside G. H.;Gastroenterology,1969
5. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers;Brumfitt W.;Antimicrob. Agents Chemother.,1984
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献